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Abstract 
Heart failure (HF) affects more than five million Americans and is one of the most 
commonly occurring reasons for admission to the hospital among adults aged 65 and 
over. Evidence is growing that the higher amount of patient engagement or activation, the 
better the health and cost outcomes. The purpose of this study was to determine if there 
was a relationship between a higher patient activation score, as determined by the PAM-
10, and completion in the heart failure transition clinic. The design for this study was a 
quantitative descriptive study. The patients were given the questionnaire prior to 
discharge from the hospital and based on the recommendations associated with the PAM-
10 tool, the level of activation can help the staff in the transition clinic to tailor specific 
interventions at the transition clinic. The population for this study was patients who were 
admitted into the hospital with a primary diagnosis of heart failure. The convenience 
sample consisted of patients who the inpatient navigator visited in the hospital and who 
agreed to participate in the study.  Those in skilled nursing facilities, cognitively impaired 
individuals, or non-English speaking patients were excluded. There were 36 participants, 
half of which scored a level three on the PAM-10, and the completion rate of those who 
were a level three was 76%. It was determined that the higher level of activation, the 
more likely that the participant was to complete the transition program.  
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CHAPTER I 
Introduction 
Heart failure affects 5.7 million Americans and is one of the most commonly 
occurring reasons that people over the age of 65 are admitted to the hospital (American 
Heart Association, 2015). When the heart muscle becomes weak (systolic heart failure) or 
stiff (diastolic heart failure), a person is considered to have heart failure (HF). HF is a 
condition in which the heart cannot pump enough blood to meet the body’s needs. In 
some cases, the heart cannot fill with enough blood, in other cases the heart cannot pump 
blood to the rest of the body with enough force. This is a chronic illness that ultimately 
has a poor prognosis and eventually worsens. There is no cure for heart failure, however, 
treatment such as medicines and lifestyle changes, can help people who have the 
condition live longer and have more active lives (National Institute of Health, 2015). 
Many people experience a fluctuation of signs and symptoms, from very little or none, to 
severe, which make activities of daily living difficult. The onset can be sudden or slow, 
precipitated by a certain event or worsen over time. These symptoms include: shortness 
of breath, fatigue, edema of the feet, ankles, legs, and abdomen, as well as fluid build-up 
in the liver and distended neck veins. According to the Centers for Disease Control 
(CDC) (2015), about half of people who develop heart failure die within five years of 
diagnosis and one in nine deaths included heart failure as a contributing cause. Heart 
failure costs $32 billion annually, which includes the cost of health care services, 
medications to treat heart failure, and missed days of work.      
The Heart Success Transition Clinic, hereafter referred to as the transition clinic, 
is a short-term clinic that was initiated after Medicare guidelines changed and the Centers 
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for Medicare and Medicaid Services (CMS) announced that payment to hospitals would 
be denied for readmissions within 30 days of discharge, for certain chronic conditions. 
Heart failure is one of the chronic conditions identified. The process for the transition 
clinic is initiated when a patient is admitted to the hospital with a primary diagnosis of 
heart failure and subsequently identified by an inpatient navigator who speaks with the 
patient while in the hospital, and gets the patient’s consent to be followed by the 
transition clinic. After this conversation, the navigator schedules him or her to be seen in 
the transition clinic within three to five days after discharge. The transition clinic is 
designed for a provider to see the patient once a week for four weeks for close monitoring 
and further titration of heart failure medications. At the end of the four weeks, the patient 
returns back to his/her primary physician or cardiologist. Once the patient comes to the 
transition clinic, he or she is seen by an Advanced Care Practitioner (ACP) who is either 
a nurse practitioner or physician assistant, a heart failure certified registered nurse, a 
pharmacist specializing in heart failure, a social worker, and a dietitian. The ACP 
discusses the specific details of the patient’s cause of heart failure, if known, and the 
treatment modalities specific to him or her. The pharmacist does a comprehensive 
medication reconciliation with the nurse, and goes over each medication with the patient 
and family members, discussing the purpose, potential side effects, and proper timing and 
dosing of each medication. The dietitian discusses a low sodium diet, fluid restriction, 
provides menus and resources to the patient and family members to help the patient be 
successful with the diet change. The social worker provides any counseling needed, as 
well as identifies patient needs related to obtaining and paying for medications, assistance 
with disability applications, helping to understand insurance benefits, and programs and 
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any other assistance programs as needed (i.e. medication copay assistance, prescription 
delivery services). The nurse reinforces any of the education provided, sends 
prescriptions electronically, coordinates appropriate follow-up with primary care 
physicians and cardiologists, provides discharge instructions, schedules any necessary 
testing, and ensures all disciplines are communicating with each other. 
Significance 
       As readmissions continue to be the focus by CMS and new diagnoses are being 
added to the non-reimbursement list with each fiscal year, it is of utmost importance to 
ensure patients receive appropriate education and understand the information provided. In 
addition to comprehension of the information given, patients must be engaged in the 
learning process. The authors of the Affordable Care Act (ACA) recognized that patient 
engagement will be the basis for successful reform and the success of patient-centered 
medical homes. Evidence is growing that the higher the amount of patient engagement, 
the better the health and cost outcomes. “Patient activation [is defined as] the skills and 
confidence that equip patients to become actively engaged in their healthcare” (Hibbard 
& Greene, 2013, p. 207). Patient engagement and patient activation are often used 
interchangeably. “Patient activation emphasizes patients’ willingness and ability to take 
independent actions to manage their health and care” (Hibbard & Greene, 2013, p. 207). 
Patient engagement, however, is used to describe a broader concept “that includes 
activation; the interventions designed to increase activation; and patients’ resulting 
behavior” (Hibbard & Greene, 2013, p. 207). According to Hibbard and Greene, “policies 
and interventions aimed at strengthening the patients’ role in managing their health care 
can contribute to improved outcomes and that patient activation can—and should—be 
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measured as an intermediate outcome of care that is linked to improved outcomes” (p. 
207). The purpose of this study was to determine the effect of patient activation on heart 
success transition clinic program completion. 
Theoretical or Conceptual Framework 
        Patient and family engagement is an important part of health care quality and 
efficiency and improved health in communities. A public engagement model that James 
Conway developed at the Institute for Healthcare Improvement, “is organized around the 
settings in which patient engagement occurs: during the care experience, within the 
microsystem of the clinic or ward, within the healthcare organization, and within the 
larger community” (Carman et al., 2013, p. 223). This model of patient engagement 
presents the different forms that engagement can take, from consultation to involvement, 
to partnership and shared leadership. The authors also described in the model at what 
levels patient engagement can occur throughout the health care system in direct care, 
organization design and governance and policy making. There is also examination of the 
factors which influence engagement that include the patient, the organization, and 
society.  
The multidimensional framework includes three critical aspects of patient 
engagement. First, engagement activities range along a continuum from consultation to 
partnership and shared leadership. Next, engagement occurs at different levels, from 
direct care, to organization design and policy making. Lastly, there are multiple factors 
that affect the ability and willingness of the patients to engage (Carman et al., 2013, p. 
225).  
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 The continuum of engagement is along the top of the model and signifies the flow 
of information between patient and provider, how active the patient is in making 
healthcare decisions and how involved the patient is in the health care and policy 
decisions. At the low-end of the continuum, patients have very little power and decision-
making. Providers and organizations make decisions based on their own agenda and 
rarely ask the patient’s input. On the high end of the continuum, there is shared power 
and responsibility between the patient and shared decision-makers.  
 The framework has engagement at multiple levels; from direct care to 
organizational design and policy making. At the direct care level, “engagement integrates 
patients’ values, experiences, and perspectives related to prevention, diagnosis, and 
treatment, including managing the patient’s health and selecting health care coverage and 
providers” (Carman et al., 2013, p. 225). At this level, patient engagement can range from 
a patient receiving information to becoming an active member in his or her health care, 
setting goals, making decisions, and being a patient proactive in his or her care. At the 
level of organizational design and governance, “engagement integrates patients; values, 
experiences, and perspectives into the design and governance of healthcare organizations 
such as hospitals, accountable care organizations [ACOs], clinics, and nursing homes” 
(Carman et al., 2013, p. 225). Patients at this level partner with leaders, managers, and 
clinicians to plan, deliver, and evaluate their care. At the partnership end of the 
continuum, patients may help with agenda setting, setting priorities, and share decision-
making responsibilities. At the policy-making level, “engagement focuses on developing, 
implementing, and evaluating national, state, and local health care policy and programs” 
(Carman et al., 2013, p. 226). This type of engagement, also coined public or citizen 
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engagement, helps to make sure that the health care system is responsive to patients’ 
perspectives. With this high level of engagement, patients collaborate with policy makers, 
participate in research, become representatives of consumer organizations, and speak on 
behalf of their peers.  
 There are three identified factors that influence engagement in the framework, 
which determine the extent that patients can engage at different levels along the 
continuum. The identified factors are grouped into three categories: patients, 
organizations, and society. Each factor can stand alone or in conjunction with one or 
more of the other factors. Factors that affect patients and their ability to engage can be 
their knowledge, beliefs, and attitudes based on their experience with the health care 
system, functional capacity, and self-efficacy. Vulnerable populations (i.e. low income, 
elderly, limited English proficiency) will face additional challenges with engagement. An 
organization can also affect how a patient is able to engage within it. Hospitals, physician 
practices, ACOs, governments, and others encourage engagement by showing that they 
value patient participation and leadership and that it is essential to achieving their goals. 
The third factor is society, which recognizes that patients and organizations operate in a 
broader sense and are influenced by social norms, purchasers’ regulations, and 
government policies at the state, local, and national level.  
 Tracking and monitoring progress on engagement requires “the use of 
parsimonious, robust measures to assess what works, how it works, and over time, 
whether engagement efforts are improving outcomes. For example, Judith Hibbard’s 
Patient Activation Measure, which assesses a person’s capacity for engagement” 
(Carman et al., 2013, pp. 227-228) can help to inform at that direct-care level. 
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Thesis Question or Hypothesis 
        Is there a relationship between a higher patient activation score, as determined by 
the PAM-10 (Patient Activation Measure), and completion of the program in the heart 
failure transition clinic? 
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CHAPTER II 
Research Based Evidence 
Because HF is such an expansive problem, it is important to find ways to ensure 
patients can appropriately manage their disease and appropriately address any changes in 
symptoms. The purpose of this thesis was to determine if there is a relationship between a 
higher patient activation score, as determined by the PAM-10 (Patient Activation 
Measure), and completion of the program in the heart failure transition clinic. Patients 
first need to become involved in their health care so they can understand how to 
effectively manage their disease. Patient engagement is an issue that is more often 
recognized as a crucial part of high quality health care.   
 The literature search was accomplished using Cumulative Index to Nursing and 
Health Literature (CINAHL), Google Scholar, and ProQuest databases. Terms searched 
for were “patient engagement”, “patient activation”, and “patient engagement in heart 
failure”. The search was refined for relevant studies, which included heart failure and 
ambulatory care to narrow down the quantity of research articles. 
Review of Literature 
Self-Management and Health Behaviors 
According to the research article by Shively et al. (2013), “few studies have 
examined whether chronic heart failure outcomes can be improved by increasing patient 
engagement in care and capabilities for self-care management” (p. 20). Shively et al. 
(2013) discussed the complexity of heart failure and its management, the fragmentation 
of follow up care, optimal HF guidelines not being followed, and the existence of 
multiple barriers that impede a patient’s ability to engage. Many heart failure 
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management programs understand that self-management strategies are a core component 
and central theme for the care of their patients. But in addition to changing the way 
organizations care for HF patients, Shively et al. (2013) discussed focusing on helping 
individuals become more informed about their illness and to actively engage in their own 
care (engagement) and improve skills for self-management.  
“Current evidence supports findings that outcomes for HF care not only depend 
on receiving better care while in the hospital but also increasingly depend on the quality 
and continuity of chronic care that a patient receives outside of the hospital” (Shively et 
al., 2013, p. 21). Important findings of this randomized, controlled trial showed that 
engagement could be improved through specific interventions and these effects have 
different outcomes based on the level of engagement. Shively et al. (2013) concluded 
from their study, which consisted of 84 participants, that tailored interventions increased 
engagement scores with improved clinical indicators. Shively et al. (2013) also discussed 
the limited understanding of how patient engagement affects self-management or if better 
self-management behavior translates into improved outcomes in high-risk HF patients. 
Overall, the findings were inconclusive as to whether patient engagement affected self-
management, which could be related to instrumentation or the interventions used. 
However, there was a significant increase in activation with the group that received 
interventions compared to the control group. Unfortunately, with the chronic nature of 
HF, it is common for patients to have fluctuations in their health status, and in turn their 
self-management requirements. 
 Barello, Graffigna, and Vegni (2012) recognized patient engagement as a major 
component of high-quality health care and has been the impetus for the start of research 
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programs and initiatives. For nurses, it is necessary to ensure patients receive better and 
reliable information and more control and influence over their healthcare. “By building 
with patients and families and fostering their engagement in the process of care, nurses 
can develop an appropriate plan of care and cure addressing issues such as symptom and 
drug management and meaningful discharge goals” (Barello et al., 2012, p. 1). While 
there are many avenues that can affect it, nurses have a central role in enhancing patient 
engagement. The primary theme is that having patients engaged in their care and having 
confidence in their self-management will help them deal more effectively with long-term 
conditions and disabilities.  
 Hibbard, Mahoney, Stock, and Tusler’s (2007) purpose was to determine if 
activation (engagement) changes over time and to determine if the activation scores can 
predict change in actual health behaviors. When clinicians can effectively champion 
activation in their patients, and make them a full partner in the care team, more effective 
and efficient care can be delivered, i.e. delivering better outcomes for less cost.  
The findings in the (Hibbard et al., 2007) study verified that activation levels 
increase over time in both the control group and the intervention group. The intervention 
consisted of a community-centered workshop given once a week for 2.5 hours over a six 
week period. Each session had a weekly topic with the classes highly participative. At the 
end of the six weeks, the participants were given a copy of the companion book used 
during the sessions and an audio relaxation tape. Of note, those in the intervention group 
had statistically significant changes in activation scores after six weeks into the study, 
while at six months the difference between these two groups had decreased because over 
time, the control group did gain some activation. The study found that activation levels 
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do change over time and that different people exhibit different change trajectories. It was 
also found that those who had changes in activation saw changes in self-management. 
When activation was increased, the patient had positive self-management behaviors. In 
short, if activation is increased behaviors will follow. 
Wasson and Coleman (2014) discussed very simply how to increase “health 
confidence” or engagement among patients in a primary care setting. In the descriptive 
study, each patient was asked How confident are you that you can control and manage 
most of your health problems? and used responses of either very confident, somewhat 
confident, not very confident, and I do not have any health problems. The patient could 
also use a 0-10 scale with 0 meaning not very confident to 10 meaning very confident. 
The idea behind this question opened up the conversation on each patient’s understanding 
and provided a time of self-reflection (p. 8).  
 Wasson and Coleman (2014) referred to a study that found that among a large 
sample of adults (75,000), those who had a higher level of engagement had fewer adverse 
experiences than those with lower levels of engagement. Those patients who were not as 
engaged had a higher incidence of emergency room visits or hospitalizations. “For both 
hospital and ambulatory care patients, health confidence is most positively associated 
with the quality of information provided to the patient and access to care” (Wasson & 
Coleman, 2014, p. 9).  
Wasson and Coleman (2014) also suggested that low levels of engagement are 
strongly associated with low financial status and high burden of illness. Care can be 
undermined by chronic pain and emotional stress and lower levels of engagement. Also, 
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the authors suggested that if the health care provider questions the patient in a judgmental 
tone or without empathy, the patient is less likely to become engaged.  
Stages of Engagement (Activation) 
The controlled trial by Hibbard et al. (2007) suggested that patients can be in one 
of four stages of engagement. The first stage is when people do not yet understand that 
they must play an active role in their health, which accounts for 12% of the sample 
population. The second stage is when people lack basic facts or do not yet have a larger 
understanding of their disease process, which was found to account for 29% (Hibbard et 
al., 2007, p. 1445) of the sample population. At stage three, people understand key 
information about their disease process, are beginning to act, but may be unsure or lack 
the skill to follow through on these behaviors, which accounts for 37% (Hibbard et al., 
2007, p. 1445) of the sample population. The fourth and final stage is where people have 
developed new behaviors but may not be able to maintain in a time of crises or stressor. 
This stage accounts for the remaining 22% (Hibbard et al., 2007, p. 1445) of the sample 
population. “These stages of activation provide insight into possible strategies for 
supporting activation among patients at different points along the continuum” (Hibbard et 
al., 2007, p. 1445).  
Tools to Assess Patient Engagement 
Wasson and Coleman (2014) discussed how to use the measure of engagement 
with patients in everyday care. First, it can be used as a vital sign for patients who have 
chronic conditions, health risks, or difficulty with follow up. Another way the measure 
can be used is as a part of a routine check-up, i.e. using the annual physical as a way to 
assess a patient’s level of engagement in their health care. A third way that a provider can 
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use the measure of engagement is for those patients who transition from another care 
setting, such as discharge from a hospital. Assessing the level of engagement and 
understanding of a patient prior to discharge can be helpful in understanding a patient’s 
individual needs prior to his or her discharge. The final way can be for patient facing a 
new diagnosis, or that are preparing for a procedure, etc. When a patient is not sure of the 
next step or what a particular procedure entails, this can cause the patient to be less 
confident in their understanding.  
While the techniques that Wasson and Coleman examined are helpful tools, 
Hibbard et al. (2007) discussed that a reliable and valid measurement tool is necessary to 
measure activation, as it opens up many possibilities for improving care and outcomes. 
Using the four stages of the Patient Activation Measure (PAM™) may help to tailor care 
plans to better fit the specific needs of each individual patient. Research is just beginning 
on the impact of interventions, and is further needed on the spontaneous increases in the 
control group that were observed in this study.  
The Responsibility of the Health Care Provider 
The commentary by Collier (2015), took a different approach to patient 
engagement and placed the onus primarily on the health care provider. 
Hospitals and health systems exist to meet the physical and psychosocial needs of 
patients and their family members. Yet many hospitals, physician practices, and 
outpatient and community-based providers continue to deliver services without 
fully engaging the patient as a partner, despite growing evidence that active 
engagement of patients and family members contributes to improved outcomes, 
experiences, and costs. (Collier, 2015, p. 168) 
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Many times, it is assumed that because health care providers give care to and for patients, 
that patients do not have any decision-making power. Not all hospitals and healthcare 
systems buy into the importance of patient engagement. Collier discussed that a change in 
the patient care culture is the only way to transform care and increase patient 
engagement. 
Also, if a patient’s progress is slower than expected regarding their level of 
engagement, pain, or emotional problems, such as depression may need to be assessed. 
These issues can deter a patient from continuing to engage in his or her health care. 
 Collier suggested three key behaviors of providers to positively impact the 
amount of progress that needs to be made with patient and family engagement. The first 
behavior is to define what patient care means to each caregiver. This definition 
encompasses the health care organization, as well as the individuals who make up its 
teams, division, professions, and leadership groups. In short, health care providers must 
make patient partnerships part of their personal culture.  
The second behavior is for healthcare providers to make the personal choice to 
change. The first step in this behavior is recognizing that a change is needed.  
One recurring factor that is critical for success in [an] organization is the inclusion 
of employees, patients, and families in the planning, implementation, and 
evaluation of the decision to act. The logic behind engaging all members early 
and often reflects a basic principle in the science of change management: change 
is personal. (Collier, 2015, p. 169) 
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In order for a health care organization to be successful in changing processes, the 
organization must help individuals move beyond passive acceptance and develop 
personal ownership in the change. Health care leaders must accept that the responsibility 
of engaging patient and families is all aspects of the care delivery system is part of the 
change process. 
 The third behavior is to develop personal resilience to sustain change. Leaders can 
anticipate numerous challenges when implementing widespread organizational change, 
including assisting employees with understanding why the change is needed, reallocating 
resources to support the change, navigating the system’s politics, and tapping into the 
personnel of team members to support the changes.  
A Culture of Engagement 
A patient engagement culture is not something that is easily instituted or quickly 
adopted through an educational program. It is an ongoing journey that benefits both 
providers and patients who are committed to see the culture change towards one of 
engagement.  
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CHAPTER III 
Methodology 
 Heart failure affects more than five million people in the United States and is one 
of the most common reasons for hospitalization and readmissions. CMS has passed 
regulations within the Medicare program to not reimburse hospitals for readmissions 
within 30 days regardless of cause for multiple disease states (HF, pneumonia, acute 
myocardial infarction, chronic obstruction pulmonary disease (COPD), and for elective 
hip and knee arthroplasty). Because heart failure is one of the conditions that affects the 
readmission problem, a transition clinic was established to help combat the readmission 
problem.  
This ACP-run clinic is heavily focused on education and self-care, in addition to 
ensuring that patients have access to necessary resources to be successful in the long-term 
management of their chronic illness. The purpose of this thesis was to determine the level 
of engagement among patients before and after participation in the transition clinic and if 
an increase in engagement helps to decrease 30-day hospital readmission. 
Study Design 
The design for this study was a quantitative descriptive study. The patient was 
given a 10- item questionnaire prior to discharge from the hospital and the level of 
activation will help the staff in the transition clinic tailor specific educational 
interventions at the transition clinic, based on recommendation associated with the PAM-
10 tool. 
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Setting and Sample 
The research took place in a large teaching hospital in an outpatient transition 
clinic. This is a short-term clinic that exists to assist with lowering readmissions of heart 
failure patients, as well as high risk medical patients who meet specific high-risk criteria. 
The population for this study consisted of patients who had been admitted into the 
hospital with a primary diagnosis of heart failure. The convenience sample was all 
patients that the inpatient navigator visits in the hospital and agrees to participate in the 
study.  Those in skilled nursing facilities or those who are cognitively impaired (i.e. 
dementia, Alzheimer’s, which is one type of dementia, senility) will be excluded from the 
sample. Fifty patients were the target sample size.  The target sample size was determined 
based on the data from the clinic schedule. The transition clinic had 111 new patients 
scheduled from January 1 to March 31, 2016. Based on the data from the first quarter of 
2016, approximately one-third of scheduled patients did not show to their appointments. 
If patients from a nursing home, cognitively impaired patients, and non-English speaking 
patients are excluded, this leaves an estimated 50 patients to participate in the study 
during the three month period from April to June 2017. Fifty patients were chosen based 
on the trends of patients arriving to appointments and continuing in the program, which is 
what the transition clinic averages in a three month period. 
Design for Data Collection 
 After consent is obtained, each participant was given the Patient Activation 
Measure® (PAM®) by the navigator in the hospital. The questionnaire was self-
administered, or assistance from a family member was obtained. Demographic 
information was collected to be able to track the patient from discharge from the hospital 
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through the completion of the transition clinic. Each patient had a number assigned to 
them so that once the program is complete, there was no identifiable information on the 
questionnaire.  
Measurement Methods 
 The tool used was the copyrighted 10-item PAM® with permission from Insignia 
Health (2014) (Patient Activation Measure License Package) to measure activation. The 
PAM®, which assesses patient knowledge, skill, and confidence for self-management, is a 
unidimensional, interval-level, Guttman-like scale (Hibbard et al., 2007, pp. 1443-4). The 
PAM® is a latent construct—a variable that cannot be measured directly but instead is 
assessed through a series of answers to questions—that gauges a person’s self-concept as 
a manager of his or her health and health care (Hibbard & Greene, 2013, p. 208). 
Permission has been granted from Insignia Health to use the tool for this research study  
Data Collection Procedure 
 Each of the PAM-10 items was scored on a 4-point scale; the summed raw score 
was converted to a 0 to 100 activation score by a pre-programmed excel program. The 
activation score was then used to identify the level of activation as provided on the 
licensed instrument instructions. The responses from the tool was tabulated and entered 
in an Excel file provided by Insignia Health, LLC to give numerical data to the 
questionnaire. The data was collected by the author during clinic visits from April to June 
2017.  
Protection of Human Subjects 
All subjects signed an informed consent form (Appendix A) after being provided 
information about the study and given the opportunity to ask questions. Participation in 
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the study was voluntary with no coercion. There was minimal risk to participate in this 
study. The only foreseeable risk was any anxiety or discomfort associated with filling out 
the questionnaire and consenting to the study. Any other risk would be the same as going 
to an office visit. Each patient received the standard of care for heart failure regardless of 
their decision to participate in the study. The study was conducted according to the rules 
given by the Institutional Review Board (IRB) of both the medical center and university. 
There was no cost to the patient or the organization for participation in the research study. 
Data Analysis 
 Data was entered into an Excel file provided by Insignia Health, LLC, per their 
copyright requirement. “The PAM® was scored on a 0-100 scale, and people were 
categorized into four levels of activation, with level one the least activated and level four 
the most activated” (Hibbard & Greene, 2013, p. 208). The questionnaire triggerd a score 
based on the answers to the questions and then gave a corresponding level to assist with 
suggested interventions that are provided with the tool. “The measure has been proved to 
be reliable and valid across different languages, cultures, demographic groups, and health 
statuses” (Hibbard & Greene, 2013, p. 208). 
 
  
20 
 
 
 
CHAPTER IV 
Results 
       The purpose of this study was to determine if there was a relationship between a 
higher patient activation score, as determined by the PAM-10 (Patient Activation 
Measure), and completion of the program in the heart failure transition clinic. Evidence is 
growing that the higher the amount of patient engagement, the better the health and cost 
outcomes. This study attempted to validate this fact and perhaps affect change in long 
term follow up among other chronic diseases.  
Sample Characteristics 
 The final sample size was 36 participants, with an initial goal of 50 participants. 
While there were more than 50 potential participants, due to the nature of the exclusion 
criteria, there were several nursing home and non-English speaking people who did not 
qualify to participate. Of the 36 participants, only two were not scheduled, both of whom 
were from out of town and followed up locally.  
The 36 participants consisted of 16 females and 20 males, aged 34 to 89, with a 
median age of 64. Most of the participants were aged between 50 and 79 (n=26), with the 
60-69 age range being the largest, consisting of 11 participants. There were 23 African 
Americans, 11 Caucasians, one Hispanic, and one American Indian who participated in 
the study.  
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Major Findings 
 Following data analysis from the 36 participants in the research study, 
approximately one-half (47%) of the participants (n=17) scored as a PAM level 3. PAM 
level 2 (n=11), which accounts for 30% of the participant population, made up most of 
the remaining participants. There were three participants who scored a PAM level 1 and 
five who scored a PAM level 4. (Figure 1). 
 
 
Figure 1. PAM-10 Level Count 
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Those who scored a 3 on the PAM-10 (n=17) had the highest percentage of 
completing all transition clinic visits (76%), while those who scored a 2 on the PAM-10 
(n=11), had the lowest completion percentage at 45%. As a whole, one-half of 
participants who were a PAM level 1 & 2 completed, while 73% of those who were a 
PAM level 3 & 4 completed the transition clinic. (Figure 2). 
Figure 2. Completion Totals by Level 
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Those participants aged 50-59 had the highest completion percentage at 85%, 
however, most of the participants who scored a level 3 on the PAM 10 were aged 60-79 
(n=10). (Figure 3). 
 
 
 
 
 
 
 
 
 
 
Figure 3. Completion Totals by Age 
 
The participants were primarily either African American or Caucasian, with 64% 
of the participants African American. While both the Hispanic and American Indian 
participants completed all visits, they only made up 5% of the population, therefore, 
African Americans had the highest attendance (n= 17) and completion (74%). Of the 11 
Caucasian participants, only one-third of Caucasian participants (n=4) attended and 
completed all visits. (Figure 4). 
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Figure 4. Completion Totals by Race 
 
As stated before, of the 36 participants, 20 were male and 16 were female. 
Females had a higher completion percentage (n=12) at 75%, while the male’s completion 
percentage (n=11) was 55%.  
Summary 
 In summary, out of the 36 participants in the study, 23 completed all visits and 13 
either did not complete or did not show up for their first visit with no rescheduled visit. 
African Americans were the largest population to be identified for the study, to attend 
and complete all visits associated with the transition clinic. Most participants were aged 
between 50 and 79 with an average age of 64. More males than females were enrolled, 
however, females had a higher completion percentage. Those in the 50-59 age range had 
the highest completion, however the largest age range for participation were those aged 
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60-69. Most of the PAM-10 scores were a level 3, which also had the highest completion 
rate.  
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CHAPTER V 
Discussion 
Due to the large number of Americans affected yearly with heart failure, it is 
imperative that health care providers continue to find ways to improve the care of patients 
while in the hospital as well as after discharge. Routine follow up is the key to successful 
outcomes with heart failure and many other chronic diseases. An important part of the 
routine care is ensuring that patients are engaged in the process of their care and 
recovery. Therefore, using the PAM-10 tool to identify where patients have a knowledge 
deficit is essential for each patient’s long-term success.   
Implication of Findings 
 Nearly one-half of participants scored a level 3 on the PAM-10. As previously 
discussed, patients who are a PAM level 3 have basic facts about their condition and 
treatment and some confidence in self-management. Those who scored a level 3 also had 
the highest completion percentage (76%) compared to the rest of the participants. Those 
who were a PAM level 2 were the least likely to complete the transition clinic (60% did 
not complete). According to Insignia Health (2014), these patients lack basic knowledge 
of their condition, treatment options and/or self-care. The have little experience or 
success with behavior change and feel less in charge of their own health and care (p. 6). 
Based on patient’s confidence with changing their behavior and how in charge of their 
health they felt, directly correlated with the likelihood of completing the transition clinic. 
Overall, two-thirds who scored either a level 1 or 2 did not finish, most likely because 
they lack the knowledge about their disease and feel like they have minimal control they 
don’t follow through with treatment modalities and follow up visits. On the other hand, 
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those who have a moderate to high level of understanding and confidence in their control 
over their healthcare were more inclined to adhere to their treatment plan because they 
understood the importance. 
 Overall, the results of the study were similar to the identified research. Those who 
have a higher level of engagement have better outcomes and less readmissions and 
emergency room visits. No patient who was a level 3 or 4 was readmitted to the hospital 
or went to the emergency room. Barello et al. (2012) discussed patient engagement being 
a major component in high-quality health care, and how necessary it is for nurses to 
provide better and reliable information so that patients have more control and influence 
over their healthcare. The researcher found that those who came to the transition clinic 
were given more specific education for heart failure and could take a more active role in 
their self-care due to better information. This finding is consistent with the literature on 
patient activation and the PAM-10 questionnaire.  
Application to Theoretical/Conceptual Framework 
 As stated previously, the multidimensional framework includes three critical 
aspects of patient engagement. First, engagement activities range along a continuum from 
consultation to involvement to partnership and shared leadership. Next, engagement 
occurs at different levels, from direct care to organization design and policy making. 
Lastly, there are multiple factors that affect the ability and willingness of the patients to 
engage (Carman et al., 2013, p. 225). Along the top of the model is the continuum of 
engagement which signifies the flow of information between patient and provider, how 
active the patient is in making healthcare and policy decisions.  
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 This study focused on the direct care level of engagement. The framework 
identified three factors that influence engagement, which determines the extent that 
patients can engage at different levels along the continuum. The identified factors are in 
the categories of patients, organizations, and society. Due to the focus of this study on the 
patient’s level of activation, i.e. engagement, the primary category is the patient. Factors 
that can influence the patient are beliefs about patient role, health literacy, and education. 
The PAM-10 addresses these beliefs in the questionnaire.  
 This framework was appropriate for this study, because it discusses what the 
PAM questionnaire measures. The transition clinic follows the direct care continuum of 
engagement for all patients who attend, which would include those who participated in 
this study. The continuum includes consultation, involvement, and partnership. The more 
engaged a patient is in their care, i.e. the higher the PAM level, the more participatory 
they will be on the continuum of engagement. In addition, the factors mentioned in the 
framework that influence engagement on a patient level (beliefs about role, health 
literacy and education) affect the PAM scores. The findings are congruent with the 
framework because those who had higher PAM scores and were shown to be more 
activated (engaged), were further on the continuum than those with lower scores.  
Limitations 
 There were several limitations that potentially could have impacted the study. The 
first was the length of the time the data was collected. Due to time constraints with 
completion deadlines, data was collected over two months instead of three months, the 
preferred length of time. Another limitation would be the sample size of 36 patients. The 
goal was for 50 patients to be enrolled, as this was what the usual average of patients that 
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attended the transition clinic who would be eligible to participate in the study, in a three 
month period.  
 A third limitation was the lack of contact with the participants in the study. 
During the process of getting this thesis approved, the researcher began to work in a 
different department and another nurse became responsible for the education provided to 
the patient. The heart failure navigator recruited all patients for the study, obtained their 
consent, and administered the questionnaire which was sent to the researcher via secure 
email. The researcher had no physical contact with any of the patients nor gave any 
education personally. This could have had the potential to change the adherence as they 
may not have been as much reinforcement with the importance of attendance. The design 
of this study did not change as there was no turnover of the Advanced Care Practitioners 
(ACP’s), so therefore the standard of care was not affected. 
The final limitation that was identified was with the study design. The participants 
did not repeat the PAM questionnaire after they completed the transition clinic, but it 
may have been more helpful to identify changes in the PAM levels after the patient were 
given education and tools for self-management. Some of the literature discussed 
improved engagement after specifically tailored education. 
Implications for Nursing 
 The research is very clear that a patient’s level of activation directly correlates to 
better outcomes with both adherence and readmissions. It is helpful to know how 
engaged a patient is in their care upon arrival to a patient care area (inpatient or 
outpatient) to better tailor education for that patient. The study determined that those who 
had a higher level of engagement were more likely to be adherent to a medication 
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regimen and attend follow up visits with their health care providers. This fact is most 
likely not limited to heart failure patients, and most likely the outcome could be 
duplicated with other disease states.  
 It would be helpful to administer the PAM-10 questionnaire to all new patients in 
an outpatient clinic so that nurses can give appropriate education based on each patient 
understanding of their disease process. Inpatient nurses could also assess activation via 
this questionnaire as well, however, the education might be different due to the acute 
nature of their encounter with the patient. It is most appropriate to administer the PAM as 
an outpatient, as there are fewer time constraints in regards to education that the nurse 
can provide. A second questionnaire could be given after the patient has been education 
and expressed understand to assess the effectiveness of the education provided. This 
would also be helpful to supply feedback on how the nursing staff can improve the 
education given to be the most effective.  
Recommendations 
 Due to the short length of the study and small sample size, a larger sample size 
may be beneficial to ascertain if the results would be different with more participants.  It 
would also be beneficial to repeat the PAM questionnaire after completion of the 
program to assess improved engagement with the participants. It might also be helpful to 
expand the study to include other chronic diseases that the transition clinic takes care of, 
such as Chronic Obstructive Pulmonary Disease (COPD) and diabetes. It would not be 
hard to have the patients complete the PAM-10 to further tailor their education based on 
their activation level. The PAM-10 is valuable for all chronic diseases and any attempt to 
improve a patient’s engagement with their chronic illness will hopefully decrease 
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hospitalizations and nonadherence to treatment regimens. The PAM could be used in all 
new patient paperwork for physician offices to assess their level of activation and 
therefore tailor any education given to each patient’s activation level. Hospitals could 
benefit from the PAM if they administered it upon admission as well, in order to 
adequately prepare and educate patients according to their level of activation and 
understanding.  
Conclusion 
 Despite the limited information, it is clear that those participants who had a higher 
PAM-10 score (more engaged) were most likely to complete the program. Additional 
studies should be done to replicate results. Evaluation of current practices in regards to 
education and evaluating understanding should be ongoing and modified to suit each 
population. The PAM-10 is a timeless model without regard for disease process and 
could be utilized in any practice setting. As stated in the research, the PAM-10, those 
who had a higher level of engagement had fewer adverse experiences than those with 
lower levels of engagement. Therefore, using the PAM-10 with patients will help to 
improve overall outcomes for patients. 
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Appendix A 
Consent to Participate in Research Study 
Page 1 of 5 
 
CAROLINAS HEALTHCARE SYSTEM 
CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
 
The effect of patient activation on transition clinic adherence 
 
INTRODUCTION 
 
The CHS Heart Success Clinic (hereafter called the transition clinic) is asking you to 
participate in this research study at Carolinas HealthCare System (CHS).  You are being 
asked to take part because you have a diagnosis of Heart Failure.  The purpose of this 
study is to determine the effect of patient activation on heart success transition clinic 
adherence. Patient activation is defined as the skills and confidence the help patients to 
become actively involved in their health care. You will be one of approximately 50 
people involved in this research project at CHS, and your participation will last for 1 
month. 
 
HOW THE STUDY WORKS 
 
Because you have been admitted to the hospital with heart failure, you are visited by a 
nurse navigator to offer you the services of the transition clinic. The transition clinic is an 
office visit that you will attend weekly for a month where you will be seen by either a 
nurse practitioner or physical assistant, a pharmacist, a social worker, and a nurse. They 
will help you learn how to manage your heart failure, learn about your medications and 
diet. 
 
Regardless of your participation in the transition clinic, you will be offered to participate 
in this study. If you agree to the study, you will be given a questionnaire called the PAM-
10 (Patient Activation Measure). This questionnaire gives a score based on your level of 
activation. If you choose to not participate in the transition clinic, your responses will be 
entered into the database for research purposes. If you agree to attend the transition clinic, 
this questionnaire will help your health care provider to give you specific care based on 
your level of understanding of heart failure and how to manage your disease at home. The 
difference in care is based on education and teaching, no standardized medical 
interventions. You will receive the standard of care for heart failure regardless of your 
participation in the study.  
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Date: 08/11/2016 
                  Expiration: 08/10/2017 
Page 2 of 5 
 
 
RISKS 
 
There is minimal risk to participate in this study. The only risk will be any anxiety or 
discomfort associated with filling out the questionnaire and consenting to the study. Any 
other risk would be the same as going to an office visit. 
 
EXCLUSION CRITERIA 
 
 Nursing home patients 
 Cognitively impaired patients 
 Non-English speaking patients 
 
BENEFITS 
 
This study may or may not improve your condition.  The information gained from your 
case may benefit others with your condition. 
 
ALTERNATIVE PROCEDURE/TREATMENT 
 
None 
 
WITHDRAWAL 
 
Your participation in this study is completely voluntary.  You should feel under no 
pressure to be in the study.  If you decide not to be in the study that will not in any way 
harm your relations with your doctors or with Carolinas HealthCare System.  You are 
free to stop being in the study if you change your mind after entering it.  This would not 
harm your relations with your doctors or Carolinas HealthCare System. 
 
 
CONFIDENTIALITY 
 
The records of this study will be kept private.  In any sort of report, we might publish, we 
will not include any information that will make it possible to identify a patient.  Your 
record for this study may, however, be reviewed and/or photocopied by the investigator 
and/or Carolinas Healthcare System.  To that extent, confidentiality is not absolute. 
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AUTHORIZATION 
 
If you wish to take part in this clinical study, you will be asked to sign this consent form.  
It allows the study sponsor and the study investigator to collect, process and pass on to 
the sponsor organizations any relevant personal health information collected from you 
during the study.  These are activities routinely carried out during all clinical studies. 
 
You have been told that personal information about you (including sensitive personal 
health information, such as your medical history and your racial/ethnic origin if relevant 
to the study) will be reviewed, collected on a computer database, stored in electronic or 
manual files, audited, and/or otherwise processed by: 
 the clinical study investigator, Megan McGraw, BSN, RN, CHFN, 
 the study sponsor and/or its associated companies, Frances Sparti, DNP, RN 
 authorized by the study sponsor, 
 Carolinas HealthCare System employees. 
 
You have been told that your personal data are being collected and processed to: 
 check your suitability to take part in the study, 
 monitor your treatment, 
 compare and pool treatment results with those of other subjects in the study, 
You have been told whenever your personal information is processed; it will be kept 
confidential and secure, to the best of our ability.  It will be used only for the purpose for 
which it was collected. 
This Authorization does not have an expiration date.  You have been told that according 
to the guidelines for good clinical practice, the study investigator and sponsor will keep 
your personal information only until the research is complete.  If you do not withdraw 
this Authorization in writing, it will remain in effect indefinitely. 
 
FINANCIAL INTEREST OF INVESTIGATOR  
 
None 
 
 
 
(This space intentionally left blank.) 
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QUESTIONS  
 
The researcher doing the study at Carolinas HealthCare System is Megan McGraw, BSN, 
RN, CHFN.  You may ask them any questions you have now.  If you have questions 
later, you may contact Megan at: 
 
Carolinas Medical Center 
1000 Blythe Boulevard 
Charlotte, NC 28203 
Telephone (980) 442-5149 
 
The Institutional Review Board is a group of people who review the research to protect 
your rights.  If you have questions about the conduct of this study or about your rights as 
a research subject, you may call the chairperson of the Institutional Review Board of 
Carolinas HealthCare System for information regarding patients' rights in a research 
study.  You can obtain the name and number of this person by calling (704) 355-3158. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(This space intentionally left blank.) 
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CONSENT  
 
I have read the above information.  I have asked any questions I had, and those questions 
have been answered.  I agree to be in this study and authorize the use of my personal 
health information.  Megan McGraw, BSN, RN or Dana Harris, BSN, RN will give me a 
copy of this form.   
 
 
__________________________________ ___________________        ___________ 
Patient [representative] Print Name  Date       Time 
 
 
__________________________________ ___________________ ____________ 
Patient [representative] Signature   Date       Time 
 
 
__________________________________ __________________        ____________ 
Signature of Person Obtaining Consent  Date       Time 
 
 
__________________________________ __________________       _____________ 
Investigator Signature    Date   Time 
 
 
Identity of representative: 
___Next of Kin 
___Parent/Guardian 
___Healthcare Power of Attorney 
 
 
 
[Portions copyright 1993, Dale Hammerschmidt, M.D.  Used with permission.] 
 
 
 
 
 
 
